5707 |
[Featured Lecture 2] Why Many Clinical Trials Fail to Change Practice - Left Main and Multivessel PCI |
Spencer B. King III |
Apr. 20. 23 |
5706 |
[Featured Lecture 1] CABG vs PCI in Left Main Disease: What Does the Randomised Data Really Tell Us |
Adrian P. Banning |
Apr. 20. 23 |
5705 |
Start Tailored Approach on Cholesterol Management for ASCVD Patients |
Jung Ho Heo |
Apr. 20. 23 |
5704 |
Eagle's Eye View: How to Get Patients on a Statin Timely and Keep Them on It |
Duk-Woo Park |
Apr. 20. 23 |
5703 |
Individual Treatment Strategy for Dyslipidemia in CAD |
Wonjae Lee |
Apr. 20. 23 |
5702 |
Real World Experience of D+STORM DES |
Hyoung-Mo Yang |
Apr. 20. 23 |
5701 |
TAVR Remaining Unmet Needs: Valve in Valve |
Cheol Woong Yu |
Apr. 20. 23 |
5700 |
TAVR Durability: Leaftlet Thrombosis and HALT |
Jeehoon Kang |
Apr. 20. 23 |
5699 |
Case presentation 1: Optimize the Vessel Preparation for a Wide Range of Lesions Treatment with DCB |
Takuma Tsuda |
Apr. 20. 23 |
5698 |
Time to Move Beyond ISR - How and When Should I Consider Drug Coated Balloon (AGENT) to Treat De Novo Lesions? |
Seung Hun Lee |
Apr. 20. 23 |